Info of Live Biotherapeutic Products

Clostridium novyi-NT in Cancer Therapy Clostridium novyi-NT Cancer

B. vulgatus and B. dorei Inhibit Atherosclerosis B. vulgatus B. dorei Atherosclerosis

Anticancer Potential of Probiotic Enterococcus lactis IW5 Anticancer Enterococcus lactis IW5

Harnessing Lactococcus lactis for Breakthroughs in Immunotherapy Lactococcus lactis Immunotherapy

Christensenella minuta in Obesity and Metabolic Health Christensenella minuta Metabolic disease

Bacteroides thetaiotaomicron Against CDI Bacteroides thetaiotaomicron CDI

Two Probiotics Combined Offers New Hypertension Therapy Probiotics Hypertension

Probiotic Treatment in Improving Major Depressive Disorder Probiotic Depressive Disorder

Enhancing Solid Tumor Targeting with Probiotic-Guided CAR-T Cells Probiotic CAR-T Cell Therapy

The Potential of Probiotics for Treating Foodborne Diseases Diarrhea

Research and Development Status of Single-Strain LBPs Single-Strain

Engineered LBP for the Treatment of Bacterial Infection Engineered Bacteria Infection

Overcoming Physiological Challenges in LBP Discovery Genomics

The Potential of Probiotics in Neurodevelopmental Disorders Neurodevelopmental Diseases

Research and Development Status of Multi-Strain LBPs Multi-Strain

Engineered LBP for the Treatment of IBD IBD

Discovery and Development Process of Live Biotherapeutics Services

Overcoming Physiological Challenges in LBP Delivery Delivery

Overview of Live Biotherapeutic Products Types of LBP

Challenges and Opportunities in Live Biotherapeutic Products Development LBP